-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LD1UIjK91mRgFRZFWDPllBXPzAqbqbSCg6/w/QX4rB29DEatKSoccpLRNPqQwcvs hmSfoqccW6mncmjencaR2A== 0001140361-07-007880.txt : 20070417 0001140361-07-007880.hdr.sgml : 20070417 20070417145935 ACCESSION NUMBER: 0001140361-07-007880 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070413 FILED AS OF DATE: 20070417 DATE AS OF CHANGE: 20070417 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TORRES LAURIE C CENTRAL INDEX KEY: 0001264186 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 07770554 MAIL ADDRESS: STREET 1: PROTEIN DESIGH LABS, INC. STREET 2: 34801 CAMPUS DRIVE CITY: FREMONT STATE: CA ZIP: 95555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 34801 CAMPUS DR CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 5105741400 MAIL ADDRESS: STREET 1: 34801 CAMPUS DR CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 4 1 doc1.xml FORM 4 X0202 4 2007-04-13 1 0000882104 PDL BIOPHARMA, INC. PDLI 0001264186 TORRES LAURIE C C/O PDL BIOPHARMA, INC. 34801 CAMPUS DRIVE FREMONT CA 94555 0 1 0 0 VP, Corporate Services Common Stock 2007-04-13 4 M 0 10935 13.29 A 35317 D Common Stock 2007-04-13 4 S 0 2187 23.72 D 33130 D Common Stock 2007-04-13 4 S 0 4375 23.69 D 28755 D Common Stock 2007-04-13 4 S 0 4373 24.26 D 24382 D Employee Stock Option (Right to Buy) 13.29 2007-04-13 4 M 0 10935 0 D 2013-11-03 Common Stock 10935 19690 D Sale was made pursuant to a 10b5-1 plan established by the reporting person. Option vests with respect to 2,187.5 shares per month and 4,377 shares remained exercisable immediately after this transaction. Only vested options are exercisable. /s/ Laurie C. Torres 2007-04-17 -----END PRIVACY-ENHANCED MESSAGE-----